Psychiatry and Neurology, Neurology · Philadelphia, PA
NPI
1285673798
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
3400 Spruce St, 2 Ravdin Building
Philadelphia, PA, 19104
Phone (215) 662-3606
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
367 services
Medicare patients, 2024
239
Average age 68
Drug cost, 2024
$2.1M
1,337 prescriptions
Company payments, 2025
$131
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy A Pruitt was code 99214 (office e&m - established), 154 times for 117 patients. In total Amy A Pruitt billed 367 services in 15 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 154 | 117 | $69.73 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 47 | 26 | $63.46 | $2,983 |
| 99213 Office E&M - Established | Facility | 40 | 34 | $44.00 | $1,760 |
| 99215 Office E&M - Established | Facility | 28 | 28 | $112.20 | $3,142 |
| 99222 Hospital E&M - Initial | Facility | 24 | 24 | $104.94 | $2,519 |
| 99204 Office E&M - New | Facility | 19 | 19 | $102.62 | $1,950 |
| 99205 Office E&M - New | Facility | 18 | 18 | $145.53 | $2,620 |
| 99223 Hospital E&M - Initial | Facility | 17 | 17 | $139.57 | $2,373 |
By year: 2022 $31K for 362 services; 2023 $29K for 351 services; 2024 $29K for 367 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy A Pruitt prescribed most often to Medicare patients was Gabapentin, with 178 prescriptions and refills. In total Amy A Pruitt wrote 1,337 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 178 | 294 | 32 | $3,947 |
| Baclofen Generic | 173 | 302 | 37 | $5,292 |
| Levetiracetam Generic | 75 | 121 | 11 | $1,337 |
| Glatiramer Acetate Generic | 67 | 67 | Under 11 | $175K |
| Glatopa Glatiramer Acetate | 65 | 65 | Under 11 | $122K |
| Kesimpta Pen Ofatumumab | 54 | 54 | Under 11 | $442K |
| Lacosamide Generic | 51 | 73 | Under 11 | $1,559 |
| Copaxone Glatiramer Acetate | 46 | 52 | Under 11 | $308K |
| Dalfampridine Er Dalfampridine | 38 | 78 | Under 11 | $27K |
| Clonazepam Generic | 29 | 45 | Under 11 | $413 |
| Methylprednisolone Sodium Succ Methylprednisolone Sod Succ | 23 | 23 | Under 11 | $951 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 23 | 26 | Under 11 | $193 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 23 | 31 | Under 11 | $517 |
| Myrbetriq Mirabegron | 23 | 29 | Under 11 | $13K |
| Tizanidine Hcl Generic | 22 | 30 | Under 11 | $242 |
Brand drugs: 239 claims; generic drugs: 1,098 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy A Pruitt $131 ($131 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $131.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $131 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.